Pennsylvania Hematology Oncology Associates (Philadelphia, PA)

Sites / USA

Pennsylvania Hematology Oncology Associates (Philadelphia, PA)

USA · PI Dr. Tanaka · activated

KRI 0.0

Patients

2

Active

0

Serious AEs

1

Open QA

0

Aged queries

0

Luna users

0

Studies & contracts

1

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma

Phase II · study completed · 64000 USD

executed

Patients

2

P2B-037

completed

P2B-121

completed

Safety

8 AEs · 1 serious

Grade 3 urinary tract infection with onset in cycle 1 (2012-10-13); serious (hospitalization); assessed as not related to study drug (unlikely); resolved 2012-10-22.

serious P2B-037

QA findings

0 open

TUMOUR ASSESSMENT OUT OF WINDOW: CT/MRI tumour assessment performed outside the +/-7-day window of the 6-weekly schedule (subject P2B-121, 2013-06-19)

resolved minor

Visits & payments

0

Nothing scheduled. Re-score risk to let the pipeline propose a visit.

Luna participants

0

No Luna participants here yet. Participants join once invited by the site.

Open Luna